Koninklijke Philips N.V. (RYLPF)
USD 23.18
(-0.01%)
USD 23.18
(-0.01%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 18.16 Billion EUR | 1.92% |
| 2022 | 17.82 Billion EUR | 3.91% |
| 2021 | 17.15 Billion EUR | -12.18% |
| 2020 | 19.53 Billion EUR | 0.27% |
| 2019 | 19.48 Billion EUR | 7.51% |
| 2018 | 18.12 Billion EUR | 1.92% |
| 2017 | 17.78 Billion EUR | -27.48% |
| 2016 | 24.51 Billion EUR | 1.12% |
| 2015 | 24.24 Billion EUR | 13.34% |
| 2014 | 21.39 Billion EUR | -8.31% |
| 2013 | 23.32 Billion EUR | -5.89% |
| 2012 | 24.78 Billion EUR | 9.78% |
| 2011 | 22.57 Billion EUR | -11.17% |
| 2010 | 25.41 Billion EUR | 9.62% |
| 2009 | 23.18 Billion EUR | -12.11% |
| 2008 | 26.38 Billion EUR | -1.68% |
| 2007 | 26.83 Billion EUR | -0.52% |
| 2006 | 26.97 Billion EUR | -11.18% |
| 2005 | 30.37 Billion EUR | 0.25% |
| 2004 | 30.29 Billion EUR | 4.52% |
| 2003 | 28.98 Billion EUR | -8.99% |
| 2002 | 31.84 Billion EUR | -1.69% |
| 2001 | 32.39 Billion EUR | -14.67% |
| 2000 | 37.96 Billion EUR | 20.33% |
| 1999 | 31.55 Billion EUR | 4.17% |
| 1998 | 30.28 Billion EUR | -11.72% |
| 1997 | 34.3 Billion EUR | 7.48% |
| 1996 | 31.91 Billion EUR | 2.02% |
| 1995 | 31.28 Billion EUR | 9.21% |
| 1994 | 28.64 Billion EUR | 5.55% |
| 1993 | 27.14 Billion EUR | 1.94% |
| 1992 | 26.62 Billion EUR | 6.75% |
| 1991 | 24.94 Billion EUR | 3.33% |
| 1990 | 24.13 Billion EUR | -4.48% |
| 1989 | 25.26 Billion EUR | 5.64% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 4.37 Billion EUR | -1.9% |
| 2024 Q2 | 4.46 Billion EUR | 7.83% |
| 2024 Q1 | 4.13 Billion EUR | -18.25% |
| 2023 Q3 | 4.47 Billion EUR | 0.02% |
| 2023 Q1 | 4.16 Billion EUR | -23.15% |
| 2023 FY | 18.16 Billion EUR | 1.92% |
| 2023 Q4 | 5.06 Billion EUR | 13.22% |
| 2023 Q2 | 4.47 Billion EUR | 7.27% |
| 2022 Q2 | 4.17 Billion EUR | 6.61% |
| 2022 Q3 | 4.31 Billion EUR | 3.18% |
| 2022 Q4 | 5.42 Billion EUR | 25.8% |
| 2022 FY | 17.82 Billion EUR | 3.91% |
| 2022 Q1 | 3.91 Billion EUR | -20.75% |
| 2021 Q3 | 4.15 Billion EUR | -1.75% |
| 2021 Q2 | 4.23 Billion EUR | 10.53% |
| 2021 FY | 17.15 Billion EUR | -12.18% |
| 2021 Q4 | 4.94 Billion EUR | 18.96% |
| 2021 Q1 | 3.82 Billion EUR | -36.23% |
| 2020 FY | 19.53 Billion EUR | 0.27% |
| 2020 Q4 | 6 Billion EUR | 20.5% |
| 2020 Q1 | 4.15 Billion EUR | -30.19% |
| 2020 Q2 | 4.39 Billion EUR | 5.67% |
| 2020 Q3 | 4.98 Billion EUR | 13.31% |
| 2019 Q4 | 5.95 Billion EUR | 26.71% |
| 2019 FY | 19.48 Billion EUR | 7.51% |
| 2019 Q1 | 4.15 Billion EUR | -25.69% |
| 2019 Q2 | 4.67 Billion EUR | 12.53% |
| 2019 Q3 | 4.7 Billion EUR | 0.66% |
| 2018 Q3 | 4.3 Billion EUR | 0.42% |
| 2018 Q4 | 5.58 Billion EUR | 29.73% |
| 2018 Q2 | 4.28 Billion EUR | 8.78% |
| 2018 FY | 18.12 Billion EUR | 1.92% |
| 2018 Q1 | 3.94 Billion EUR | -25.66% |
| 2017 Q3 | 4.14 Billion EUR | -3.4% |
| 2017 FY | 17.78 Billion EUR | -27.48% |
| 2017 Q4 | 5.3 Billion EUR | 27.84% |
| 2017 Q2 | 4.29 Billion EUR | -24.98% |
| 2017 Q1 | 5.72 Billion EUR | -20.94% |
| 2016 Q4 | 7.24 Billion EUR | 22.75% |
| 2016 Q2 | 5.86 Billion EUR | 6.24% |
| 2016 Q1 | 5.51 Billion EUR | -22.24% |
| 2016 FY | 24.51 Billion EUR | 1.12% |
| 2016 Q3 | 5.89 Billion EUR | 0.63% |
| 2015 Q4 | 7.09 Billion EUR | 21.57% |
| 2015 Q2 | 5.97 Billion EUR | 11.89% |
| 2015 Q3 | 5.83 Billion EUR | -2.31% |
| 2015 FY | 24.24 Billion EUR | 13.34% |
| 2015 Q1 | 5.33 Billion EUR | -18.31% |
| 2014 FY | 21.39 Billion EUR | -8.31% |
| 2014 Q3 | 5.54 Billion EUR | 4.8% |
| 2014 Q2 | 5.29 Billion EUR | 5.44% |
| 2014 Q1 | 5.02 Billion EUR | -26.17% |
| 2014 Q4 | 6.53 Billion EUR | 17.83% |
| 2013 Q2 | 5.65 Billion EUR | 7.53% |
| 2013 Q1 | 5.25 Billion EUR | -26.57% |
| 2013 Q4 | 6.79 Billion EUR | 21.02% |
| 2013 Q3 | 5.61 Billion EUR | -0.64% |
| 2013 FY | 23.32 Billion EUR | -5.89% |
| 2012 Q4 | 7.16 Billion EUR | 16.88% |
| 2012 Q3 | 6.12 Billion EUR | 3.99% |
| 2012 Q2 | 5.89 Billion EUR | 5.06% |
| 2012 FY | 24.78 Billion EUR | 9.78% |
| 2012 Q1 | 5.6 Billion EUR | -16.45% |
| 2011 Q1 | 5.25 Billion EUR | -28.88% |
| 2011 Q3 | 5.39 Billion EUR | 3.47% |
| 2011 Q4 | 6.71 Billion EUR | 24.43% |
| 2011 FY | 22.57 Billion EUR | -11.17% |
| 2011 Q2 | 5.21 Billion EUR | -0.84% |
| 2010 Q1 | 5.67 Billion EUR | -21.84% |
| 2010 FY | 25.41 Billion EUR | 9.62% |
| 2010 Q4 | 7.39 Billion EUR | 20.02% |
| 2010 Q3 | 6.15 Billion EUR | -0.52% |
| 2010 Q2 | 6.19 Billion EUR | 9.05% |
| 2009 Q4 | 7.26 Billion EUR | 29.21% |
| 2009 FY | 23.18 Billion EUR | -12.11% |
| 2009 Q1 | 5.07 Billion EUR | -33.61% |
| 2009 Q2 | 5.23 Billion EUR | 3.05% |
| 2009 Q3 | 5.62 Billion EUR | 7.48% |
| 2008 Q4 | 7.64 Billion EUR | 20.82% |
| 2008 Q1 | 5.96 Billion EUR | -27.43% |
| 2008 Q2 | 6.46 Billion EUR | 8.5% |
| 2008 Q3 | 6.32 Billion EUR | -2.2% |
| 2008 FY | 26.38 Billion EUR | -1.68% |
| 2007 Q3 | 6.52 Billion EUR | 6.99% |
| 2007 FY | 26.83 Billion EUR | -0.52% |
| 2007 Q1 | 5.98 Billion EUR | -26.49% |
| 2007 Q2 | 6.09 Billion EUR | 1.84% |
| 2007 Q4 | 8.21 Billion EUR | 25.89% |
| 2006 FY | 26.97 Billion EUR | -11.18% |
| 2006 Q4 | 8.14 Billion EUR | 29.19% |
| 2006 Q3 | 6.3 Billion EUR | -17.08% |
| 2006 Q2 | 7.6 Billion EUR | 3.19% |
| 2006 Q1 | 7.37 Billion EUR | -18.53% |
| 2005 Q1 | 6.63 Billion EUR | -27.59% |
| 2005 Q3 | 7.61 Billion EUR | 7.71% |
| 2005 Q2 | 7.07 Billion EUR | 6.63% |
| 2005 Q4 | 9.04 Billion EUR | 18.75% |
| 2005 FY | 30.37 Billion EUR | 0.25% |
| 2004 FY | 30.29 Billion EUR | 4.52% |
| 2004 Q2 | 7.27 Billion EUR | 9.82% |
| 2004 Q3 | 7.22 Billion EUR | -0.62% |
| 2004 Q4 | 9.16 Billion EUR | 26.73% |
| 2004 Q1 | 6.62 Billion EUR | -26.27% |
| 2003 Q2 | 6.51 Billion EUR | 0.59% |
| 2003 Q3 | 6.98 Billion EUR | 7.13% |
| 2003 Q4 | 8.98 Billion EUR | 28.61% |
| 2003 FY | 28.98 Billion EUR | -8.99% |
| 2003 Q1 | 6.48 Billion EUR | -27.83% |
| 2002 Q4 | 8.98 Billion EUR | 22.95% |
| 2002 Q2 | 7.97 Billion EUR | 5.04% |
| 2002 Q1 | 7.59 Billion EUR | 4.06% |
| 2002 FY | 31.84 Billion EUR | -1.69% |
| 2002 Q3 | 7.3 Billion EUR | -8.39% |
| 2001 Q3 | 7.81 Billion EUR | 1.85% |
| 2001 Q1 | 8.21 Billion EUR | -25.99% |
| 2001 Q2 | 7.67 Billion EUR | -6.53% |
| 2001 Q4 | 7.29 Billion EUR | -6.69% |
| 2001 FY | 32.39 Billion EUR | -14.67% |
| 2000 Q4 | 11.09 Billion EUR | 18.34% |
| 2000 Q3 | 9.37 Billion EUR | 2.24% |
| 2000 Q2 | 9.17 Billion EUR | 10.09% |
| 2000 Q1 | 8.33 Billion EUR | -14.01% |
| 2000 FY | 37.96 Billion EUR | 20.33% |
| 1999 Q4 | 9.68 Billion EUR | 25.19% |
| 1999 Q1 | 6.83 Billion EUR | -2.17% |
| 1999 Q2 | 7.28 Billion EUR | 6.56% |
| 1999 FY | 31.55 Billion EUR | 4.17% |
| 1999 Q3 | 7.73 Billion EUR | 6.19% |
| 1998 Q2 | 8.02 Billion EUR | 0.78% |
| 1998 Q4 | 6.99 Billion EUR | -3.46% |
| 1998 FY | 30.28 Billion EUR | -11.72% |
| 1998 Q1 | 7.95 Billion EUR | -25.09% |
| 1998 Q3 | 7.24 Billion EUR | -9.72% |
| 1997 Q3 | 8.55 Billion EUR | 9.6% |
| 1997 FY | 34.3 Billion EUR | 7.48% |
| 1997 Q1 | 7.4 Billion EUR | -22.63% |
| 1997 Q2 | 7.8 Billion EUR | 5.37% |
| 1997 Q4 | 10.62 Billion EUR | 24.2% |
| 1996 FY | 31.91 Billion EUR | 2.02% |
| 1996 Q4 | 9.57 Billion EUR | 28.06% |
| 1996 Q3 | 7.47 Billion EUR | -2.14% |
| 1996 Q2 | 7.63 Billion EUR | 0.82% |
| 1996 Q1 | 7.57 Billion EUR | -23.62% |
| 1995 Q2 | 7.05 Billion EUR | 5.97% |
| 1995 Q3 | 7.33 Billion EUR | 4.07% |
| 1995 FY | 31.28 Billion EUR | 9.21% |
| 1995 Q4 | 9.92 Billion EUR | 35.2% |
| 1995 Q1 | 6.65 Billion EUR | -9.08% |
| 1994 Q2 | 7.33 Billion EUR | -3.48% |
| 1994 Q3 | 7.1 Billion EUR | -3.08% |
| 1994 Q4 | 7.31 Billion EUR | 2.94% |
| 1994 FY | 28.64 Billion EUR | 5.55% |
| 1994 Q1 | 7.59 Billion EUR | -2.72% |
| 1993 Q3 | 6.44 Billion EUR | -1.44% |
| 1993 FY | 27.14 Billion EUR | 1.94% |
| 1993 Q2 | 6.53 Billion EUR | 3.64% |
| 1993 Q1 | 6.3 Billion EUR | -33.7% |
| 1993 Q4 | 7.81 Billion EUR | 21.25% |
| 1992 Q3 | 6.03 Billion EUR | -3.4% |
| 1992 FY | 26.62 Billion EUR | 6.75% |
| 1992 Q1 | 5.62 Billion EUR | -9.54% |
| 1992 Q4 | 9.51 Billion EUR | 57.64% |
| 1992 Q2 | 6.24 Billion EUR | 10.99% |
| 1991 Q4 | 6.22 Billion EUR | -25.72% |
| 1991 Q1 | 1.59 Billion EUR | -74.41% |
| 1991 Q2 | 5.84 Billion EUR | 265.85% |
| 1991 Q3 | 8.37 Billion EUR | 43.37% |
| 1991 FY | 24.94 Billion EUR | 3.33% |
| 1990 Q4 | 6.24 Billion EUR | -13.31% |
| 1990 Q2 | 5.85 Billion EUR | 3.15% |
| 1990 Q1 | 5.67 Billion EUR | -30.82% |
| 1990 Q3 | 7.19 Billion EUR | 22.89% |
| 1990 FY | 24.13 Billion EUR | -4.48% |
| 1989 Q1 | 5.22 Billion EUR | 5.7% |
| 1989 Q2 | 5.81 Billion EUR | 11.32% |
| 1989 FY | 25.26 Billion EUR | 5.64% |
| 1989 Q3 | 5.82 Billion EUR | 0.04% |
| 1989 Q4 | 8.21 Billion EUR | 41.07% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Polarean Imaging plc | 890.93 Thousand USD | -2039222.822% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -644788.56% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -2542057.077% |
| IR-Med Inc. | - USD | -Infinity% |
| Avitar, Inc. | 3.1 Million USD | -584820.895% |
| AVITA Medical, Inc. | 50.56 Million USD | -35834.807% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -2212.51% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -20977847.119% |
| QHSLab, Inc. | 1.4 Million USD | -1289400.672% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -2212.51% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | -34434.603% |
| Escalon Medical Corp. | 11.98 Million USD | -151542.001% |
| Aurora Spine Corporation | 14.52 Million USD | -125027.097% |
| BrainsWay Ltd. | 31.78 Million USD | -57062.183% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -7058590.982% |
| Hamilton Thorne Ltd. | 68.45 Million USD | -26440.24% |
| Vivos Inc. | 19.5 Thousand USD | -93174258.974% |
| MicroPort Scientific Corporation | 950.72 Million USD | -1811.068% |
| Kelyniam Global, Inc. | 2.67 Million USD | -679786.707% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -8918601.342% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -21505747.261% |
| Nanomix Corporation | 15.45 Thousand USD | -117598605.502% |
| Theraclion SA | 1.82 Million USD | -996979.937% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -2746328.841% |
| Positron Corporation | 734.66 Thousand USD | -2472996.618% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -1346941.239% |
| Lombard Medical, Inc. | 12.16 Million USD | -149205.613% |
| ALR Technologies Inc. | 7468.00 USD | -243291276.54% |
| Stratec SE | 289.14 Million USD | -6183.616% |
| Vycor Medical, Inc. | 1.46 Million USD | -1243837.44% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -4502381.829% |
| SANUWAVE Health, Inc. | 20.39 Million USD | -88972.458% |
| VMS Rehab Systems, Inc. | 71.70 USD | -25340306734.031% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -18539695.918% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -2520998.188% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -638469.918% |
| Urologix, Inc. | 14.23 Million USD | -127536.108% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -550013.162% |
| SS Innovations International, Inc. | 5.87 Million USD | -308911.839% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -45224542.19% |
| Smith & Nephew plc | 5.68 Billion USD | -219.725% |
| NIOX Group Plc | 46.84 Million USD | -38684.197% |
| Fuse Medical, Inc. | 16.11 Million USD | -112642.51% |
| Broncus Holding Corporation | 10.25 Million USD | -177072.111% |
| Brain Scientific Inc. | 214.56 Thousand USD | -8467769.727% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -918564.168% |
| Health Logic Interactive Inc. | - USD | -Infinity% |